We are live on
!
Find out more
EAM
Eventide Asset Management Portfolio holdings
AUM
$6.05B
1-Year Est. Return
76.64%
This Fund
S&P 500
This Quarter
Est. Return
+16.39%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.4B
AUM Growth
+$319M
(+5.3%)
Cap. Flow
-$191M
Cap. Flow
% of AUM
-2.99%
Top 10 Holdings %
Top 10 Hldgs %
23.07%
Holding
290
New
50
Increased
129
Reduced
80
Closed
21
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
+$43.3M |
| 2 |
Liberty Energy
LBRT
|
+$32.9M |
| 3 |
DexCom
DXCM
|
+$30.7M |
| 4 |
Apogee Therapeutics
APGE
|
+$27.5M |
| 5 |
Monolithic Power Systems
MPWR
|
+$26.1M |
Top Sells
| 1 |
Insmed
INSM
|
+$95.2M |
| 2 |
VRNA
Verona Pharma
VRNA
|
+$72.7M |
| 3 |
Guardant Health
GH
|
+$72.5M |
| 4 |
Celcuity
CELC
|
+$63.7M |
| 5 |
Evolent Health
EVH
|
+$53.2M |
Sector Composition
| 1 | Healthcare | 42.37% |
| 2 | Industrials | 17.69% |
| 3 | Technology | 15.85% |
| 4 | Consumer Discretionary | 6.94% |
| 5 | Utilities | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
TG Therapeutics
TGTX
$8.4B
| $21.4M | 0.33% |
716,414
-238,117
| -25% | -$7.78M |
|
102
MSCI
MSCI
$44.5B
| $20.9M | 0.33% |
36,280
+980
| +3% | +$550K |
|
103
Rockwell Automation
ROK
$52.3B
| $20.3M | 0.32% |
52,191
+372
| +0.7% | +$140K |
|
104
Praxis Precision Medicines
PRAX
$9.14B
| $19.8M | 0.31% |
+67,100
| New | +$12.5M |
|
|
TTAN
105
ServiceTitan Inc
TTAN
$7.64B
| $19M | 0.3% |
178,616
+169,634
| +1,889% | +$16.6M |
|
106
American Express
AXP
$242B
| $18.6M | 0.29% |
50,106
+361
| +0.7% | +$129K |
|
107
Amylyx Pharmaceuticals
AMLX
$2.02B
| $18.3M | 0.29% |
1,513,148
+648
| +0% | +$8.8K |
|
108
IDEX
IEX
$16.5B
| $17.7M | 0.28% |
99,135
+2,753
| +3% | +$470K |
|
109
Privia Health
PRVA
$3.53B
| $17.5M | 0.27% |
737,694
| – | – |
|
110
Vertiv
VRT
$117B
| $17.2M | 0.27% |
105,999
+102,447
| +2,884% | +$17.8M |
|
111
Vital Farms
VITL
$562M
| $16.6M | 0.26% |
517,988
+1,260
| +0.2% | +$44.3K |
|
|
EVMN
112
Evommune Inc
EVMN
$432M
| $16.5M | 0.26% |
+961,525
| New | +$18.1M |
|
113
Broadcom
AVGO
$1.85T
| $16.4M | 0.26% |
47,308
-1,545
| -3% | -$553K |
|
114
Baker Hughes
BKR
$57.3B
| $16M | 0.25% |
349,974
+319,345
| +1,043% | +$15.1M |
|
115
Xylem
XYL
$28.9B
| $15.4M | 0.24% |
113,301
+453
| +0.4% | +$65.2K |
|
|
HTFL
116
Heartflow Inc
HTFL
$2.2B
| $14.7M | 0.23% |
505,989
+421,999
| +502% | +$13.6M |
|
117
Invivyd
IVVD
$236M
| $14.3M | 0.22% |
+5,809,256
| New | +$12.1M |
|
118
Olema Pharmaceuticals
OLMA
$1.04B
| $14.2M | 0.22% |
+569,000
| New | +$10.1M |
|
119
S&P Global
SPGI
$130B
| $14.2M | 0.22% |
26,995
+2,952
| +12% | +$1.46M |
|
|
GRMN
120
Garmin
GRMN
$46.6B
| $14.1M | 0.22% |
69,476
+51,191
| +280% | +$11.1M |
|
121
Edgewise Therapeutics
EWTX
$4.27B
| $14.1M | 0.22% |
568,310
| – | – |
|
122
Alnylam Pharmaceuticals
ALNY
$37.6B
| $13.5M | 0.21% |
34,035
-67,704
| -67% | -$30M |
|
123
monday.com
MNDY
$3.51B
| $13.5M | 0.21% |
91,472
-1,139
| -1% | -$192K |
|
|
MAZE
124
Maze Therapeutics
MAZE
$1.65B
| $13.4M | 0.21% |
+324,041
| New | +$11.1M |
|
|
BBOT
125
BridgeBio Oncology
BBOT
$707M
| $13.4M | 0.21% |
1,082,362
| – | – |
|
Similar funds
AWA
HPG
CDDEC
EMPI
RCG
WHRC
GA
JWBC